Source: Eur Respir J, 54 (3) 1901363; 10.1183/13993003.01363-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Milo A. Puhan. Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice. Eur Respir J, 54 (3) 1901363; 10.1183/13993003.01363-2019

Member's Comments

No comment yet.

Related content which might interest you: Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I Source: Annual Congress 2003 - Burden of asthma Year: 2003 Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Source: Eur Respir J 2008; 32: 945-952 Year: 2008 Polish Spirometry Day 2013 as a way to increase public awareness concerning the causes, course and consequences of chronic respiratory diseases Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 The growing chronic disease burden in Europe: a role for respiratory health professionals? Source: Eur Respir J 2014; 43: 1249-1251 Year: 2014 Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Evidence base of lung function indices in diagnosis and follow-up of chronic respiratory diseases in primary care Source: Annual Congress 2012 - Primary Care Programme Year: 2012 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 The effect of regional differences on visual arts interpretation in exacerbation and stable periods of chronic airway diseases Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Increased self-management capacity leads to improved health outcomes for chronic lung disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 Exploring the provision of supportive care for people with severe, potentially life limiting chronic obstructive pulmonary disease in Malaysia: a qualitative study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Cleaning agents and chronic lung disease: does the evidence support a link with COPD? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 The global burden of chronic respiratory diseases Source: ISSN=ISSN 1810-6838, ISBN=, page=20 Year: 2006 Impact of preventing exacerbations on deterioration of health status in COPD Source: Eur Respir J 2004; 23: 698-702 Year: 2004